Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HLI
HLI logo

HLI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Houlihan Lokey Inc (HLI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
158.780
1 Day change
-0.68%
52 Week Range
211.780
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Houlihan Lokey Inc (HLI) is not a strong buy at this time for a beginner investor with a long-term strategy. The technical indicators suggest the stock is overbought, and hedge funds are selling heavily. While the company has demonstrated strong financial growth in its latest quarter, the lack of recent positive news, declining analyst price targets, and no significant trading signals make it prudent to hold off on purchasing the stock currently.

Technical Analysis

The MACD is positive but contracting, indicating weakening momentum. RSI at 82 suggests the stock is overbought. Moving averages are converging, and the stock is trading near its resistance level (R1: 159.496). The next support level is significantly lower at S1: 139.678.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
7

Positive Catalysts

  • The company reported strong financial performance in Q3 2026, with revenue up 13.03% YoY, net income up 22.29% YoY, and EPS up 22.30% YoY.

Neutral/Negative Catalysts

  • Hedge funds are selling heavily, with a 102.34% increase in selling activity over the last quarter. Analysts have recently lowered price targets, reflecting cautious sentiment. No recent news or congress trading data to support positive momentum.

Financial Performance

In Q3 2026, Houlihan Lokey reported revenue of $717.07M (+13.03% YoY), net income of $116.55M (+22.29% YoY), and EPS of $1.70 (+22.30% YoY). Gross margin remained unchanged.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets recently, with Morgan Stanley reducing to $193 from $205, Keefe Bruyette to $177 from $214, and UBS to $163 from $196. Sentiment remains mixed, with some maintaining Overweight or Outperform ratings, but cautious optimism prevails amid market volatility.

Wall Street analysts forecast HLI stock price to rise
4 Analyst Rating
Wall Street analysts forecast HLI stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 159.870
sliders
Low
193
Averages
215.5
High
235
Current: 159.870
sliders
Low
193
Averages
215.5
High
235
Morgan Stanley
Ryan Kenny
Overweight
downgrade
$205 -> $193
AI Analysis
2026-04-09
Reason
Morgan Stanley
Ryan Kenny
Price Target
$205 -> $193
AI Analysis
2026-04-09
downgrade
Overweight
Reason
Morgan Stanley analyst Ryan Kenny lowered the firm's price target on Houlihan Lokey to $193 from $205 and keeps an Overweight rating on the shares. The firm expects midcap advisor management teams to express cautious optimism amid recent volatility, but comp ratios could disappoint as managements await clarity on the full-year revenue environment, the analyst tells investors in a preview for the group.
Keefe Bruyette
Outperform
to
NULL
downgrade
$214 -> $177
2026-04-08
Reason
Keefe Bruyette
Price Target
$214 -> $177
2026-04-08
downgrade
Outperform
to
NULL
Reason
Keefe Bruyette lowered the firm's price target on Houlihan Lokey to $177 from $214 and keeps an Outperform rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HLI
Unlock Now

People Also Watch